Schouw & Co A/S
CSE:SCHO
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
427.5
597
|
Price Target |
|
We'll email you a reminder when the closing price reaches DKK.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
Abbvie Inc
NYSE:ABBV
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Realty Income Corp
NYSE:O
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Welcome
to
our
2021
Annual
Presentation.
Once
again,
we
faced
a
turbulent
and
challenging
year.
And
I
also –
I
think
I
can
say
that
it
has
been
a
very
difficult
business
climate
throughout
the
year.
In
spite
of
that,
I
think
we
have
delivered
a
very
satisfactory
development
in
Schouw &
Co.
Three
of
our operating
companies
has
really
performed
very,
very
well
even
under
these
circumstances.
So,
I
have
to
say
that
our
management
really
executed
well,
and
all
our
10,000 employees
have
worked
very
hard
throughout
the
year.
I
think
if
you
look
at
our
annual
report
this
year, you'll
also
see
that
we
have
upgraded
our
ESG
reporting
quite
a
lot
and
it's
part
of
the
way
we
are
starting
to
think
in
Schouw
&
Co.,
and
we
will
continue
to
upgrade
and
be
proactive
on
the
ESG
strategy
throughout
the
coming
years.
Just
a
very
quick
glance
on
our
portfolio,
what
does
the
group
or
the
conglomerate
consist
of?
Many
of
you
know
it
very
well,
but
we
have
six
strong
independent
businesses,
all
of
them
within
the
business-to-business
segment
and
each
of
them
holding
a
leading
position
in
their
segment,
something
we
really
put
a
lot
of
emphasis
on
that.
You
need
to
be
leading
in
your
segment
to
be
able
to
be
profitable
and
also
to
build
a
future.
Let
me
give
you
a
very,
very
fast
view
into
the
group.
And
then
after
that,
I
will
take
a
short,
fast
dive
into
each
of
our
companies
to
give
you
an
update
on
what
happened
throughout
the
year.
Looking
at
it
from
an
overall
point
of
view,
I
think
it
came
– yes,
sorry,
yes.
Then
we
have
had
a
very
strong
growth
in
2021.
We
continue
to
grow.
Top
line
was
up
14%
to
DKK
24.2
billion.
Out
of
that,
we
had
organic
growth
of
about
12%.
So,
most
of
our
growth
in
2021
came
from
organic.
We
had
two
minor
acquisitions
impacting
the
top
line
also.
We
delivered
what
we
ourselves
say
a
very
satisfactory
EBITDA
even
it
didn't
grow
compared
to
2020.
We
had
an
EBITDA
of
DKK
2.2
billion
equals
9.1%
in
EBITDA.
Looking
at
our
EBITDA
and
I
said
it's
very
satisfactory,
I
think
also
we
have
to
bear
in
mind
that
costs
around
all
companies
have
exploded
as
input
cost
on
raw
material,
energy,
et cetera.
And
we
have
worked
very,
very
hard
to
offset
these
costs
to
all
our
companies.
But
looking
at
it
at
the
end
of
the
day,
these
cost
increases
had
a
negative
impact
of
around
DKK 150
million
on
our
results.
So,
with
that
in
mind,
I
think
it's
very
satisfactory.
Our
return
on
invested
capital
was
slightly
down
due
to
a
huge
increase
in
our
net
working
capital.
I
will
elaborate
a
little
bit
on
our
net
working
capital
development
on
one
of
the
next
slides.
But
looking
at
the
table
there,
all
in
all,
we
are
satisfied
with
the
year.
Also,
we
had
a
14%
increase
in
earnings
per
share.
So,
as I
said,
looking
a little
bit
deeper
into
our
net
working
capital,
we
saw
an
increase
of
close
to
DKK
1.5
billion
or
47%
of
our
net
working
capital.
A
lot
of
reasons
behind
that
I
think
the
graph
there
also
gives
a
good
view
on
what
has
happened.
Part
of
the
increase
is,
of
course,
we
have
had
higher
activity.
We
have
seen
increasing
raw
material
prices,
all
material
prices
in
general.
We
have
added
a
new
business
into
that.
And
then
we
took
at
the
beginning
of
2021
a
strategic
decision
that
we
wanted
to
build
inventories
on
what
we
call
critical
components
to
be
able
to
supply
our
customers
around
the
globe
and
also
to
meet
the
contracts,
et cetera,
we
have
had
from
or
we
have
from
a
lot
of
our
companies.
And
we
also
thought
that
we
have
the
financial
capabilities
and
opportunities
to
do
that
and
we
think
it
has
been
a
strategic,
very
good
decisions.
We
are
standing
strong
with
our
customers
and
being
able
to
supply
in
most
cases.
So,
that's
part
of
the
net
working
capital.
You
will
also
see
that
it
is
our
inventory
days
increasing
from
76
days
in
average
to
99
throughout
2021.
Looking
a
little
bit
also
on
our
net
interest-bearing
debt
increasing
in
2021,
also
an
increase
that
we
have
managed
ourselves.
Part
of
it
of
course
coming
from
this
net
working
capital
increase,
but
also
investments
in
CapEx,
DKK
745
million
CapEx
investments,
small
acquisitions
and
so
on
then
of
course
also
our
dividend
and
our
share
buyback
program,
which
we
initiated
at
the
start
of
– we
initiated
last
year
has
been
good
for
us
also.
So,
all
in
all,
net
interest-bearing
debt
of
nearly DKK
2.8
billion.
However,
our
gearing
still
at
a
low
level.
Net
interest-bearing
debt
on
EBITDA
is
1.2
times.
I
think
that
also
shows
clearly
that
we
have
sufficient
room
for
growth
and
also
opportunities
to
seek
opportunities,
new
opportunities,
whenever
they
arise
and
it's
part
of
the
way
we
think
strategy
in
Schouw
& Co.
that
we really
want
to
have
this
financial
strength.
We
call
it
a
little
bit
dry
powder
we
have
in
the
basement.
And
then
we
intend,
of
course,
to
use
that
when
we
see
what
we
expect
as
value-creating
opportunities.
As
I
also
said,
CapEx
continued
also
in
2021.
We
had
a
slowdown
in
2020.
That
was
more
because
we
were
at
the
end
of
a
rather
big
investment
program.
And
then
we
started
up
investing
again
in
2021.
Even
the
business
climate
has
been
difficult.
We
do
not
stop
investing
and
thinking
in
future.
And
we
have,
as
I
said,
the
financial
capabilities
for
doing
that.
So
in
2021,
DKK
745
million
in
CapEx
and
a
lot
of
new
CapEx
decisions,
in
fact,
taking
– was
taken
in
2021,
which
will
affect
the
coming
years.
In
2022,
we
expect
CapEx
to
be
in
the
area
of
around
DKK
1.3
billion.
Most
important,
we
have
in
our
two
Fibertex
companies
initiated
rather
large
investments.
One
is
in
Fibertex
Personal
Care,
a
new
line
in
Malaysia,
and
two,
new
lines
for
Fibertex
Nonwovens.
Besides
that,
we
are
extending
capacity
at
some
of
our
factories,
especially
in
GPV
in
Asia,
meaning
in
Thailand
and
in
Sri
Lanka.
So
we
continue
to
invest.
It's
part
of
our
DNA,
and
it's
also
necessary
to
be
able
to
reach
our
rather
ambitious
2025
objective
or
ambition.
We
just
disclosed
that
we
expect
to
be
able
to
deliver
a
top
line
of
around
$35
billion
in
2025
with
EBITDA
of
at
least
DKK
3
billion.
So,
we
need
to
continue
to
prepare
for
that
and
pave
the
road
for
this
growth.
Let
me
then
dive
very
fast
into
each
of
the
companies
in
our
portfolio
starting
with
the
largest
company
in
our
portfolio,
BioMar.
As
you
see also
here,
BioMar
continue
to
grow.
Revenue
was
around
DKK
13
billion,
growth
of
14%.
However,
volume
growth
was
8%,
meaning
that
increasing
raw
materials
hit
the
top
line
positive,
but
still
very
satisfactory
that
we
were
able
to
grow
8%
to
producing
and
selling
1.44
million
tonnes
of
fish
feed.
And
those
knowing
about
volume
and
so
on
also
know
that
1.4
million
tonnes,
that's
quite
a
lot.
It
demands
a
lot
of
trucks
and
ships
to
carry
that
around
in
the
world.
EBITDA
was
unfortunately
declining
from
DKK
972
million
to
DKK
911
million. Reasons
were,
among
other
things,
lower
volume
in
Chile.
Chile
has
always
been
a
very
profitable
market
for
us,
was
seeing
lower
volumes
due
to
less
fish
at
sea
because
salmon
prices
at
the
start
of
2021
was
low.
We
have
really
had
a
lot
of
increasing
raw
materials
and
difficult
to
pass
all
of
them
on
to
customers.
Energy
has
increased
a
lot.
Energy
is
big
–
BioMar
is
a
big
energy
consumer
in
general.
And
then,
we
also
saw
on
the
positive
side
a
very
good
development
in
what
we
call
our value-added
products
or
functional
feed
continued
to
develop
positive.
So,
looking
at
it
in
general,
we
are
very
satisfied
with
the
good
volume
development
we
have
had
in
most
markets.
Chile
were
hit
on
the
volume,
and
we
also
were
able
to
offset
most
of
the
very,
very
explosive
cost
increases
we
saw.
Also
positive
to
see
that
a
strong
development
in
what
we
call
associated
companies.
Our
salmon
farming
company,
Salmones
Austral
in
Chile
performed
very
well.
Results
from
associates
was
up
from
negative
DKK 35
million
EBIT
--
DKK
35
million
in
[ph]
2022 (00:10:27),
plus
DKK 45
million
in
2021,
so
that
was
very
satisfactory.
We
are
investing
still
in
BioMar,
two
new
extrusion
lines
announced
to
be
invested
in
Ecuador.
Very
good
development.
We
see
a
change
of
feeding
or
feed
production
in
Ecuador
moving
away
from
a
more
simple,
basic
production
methods
and
into
advanced
extrusion.
Also
started
up
our
new
venture
in
Vietnam,
has
been
very
difficult
because
we
were
not
able
to
go
and
visit
Vietnam.
But
hopefully
now,
we
have
people,
our
feet
on
the
ground
in
Vietnam
and
start
to
see
this
will
develop.
Also
in
2022,
we
expect
further
growth
and
improved
profitability.
Turnover
in
the
area
of
DKK
14
billion
to DKK
15
billion.
EBITDA
expected
in
a
range
from
DKK 980
million
to
DKK
1.040
billion.
We
will see
what
is
going
to
drive
that
will
be,
of
course,
growth
and
volume,
strong
margin
management,
ability
to
pass
on
these
increasing
raw
materials.
And
then
we
expect
to
change
the
tide
in
Chile.
So,
that's
the
main
reasons
for
the
development
in
BioMar.
From
BioMar
moving
on
to
FPC,
has
been
a
very
challenging
year
for
FPC
because
of
their
number
one,
raw
material
polypropylene
has
been
so
volatile
and
has
affected
profitability.
Turnover
increased
6%
to
DKK
2.2
billion
only
driven
by
high
raw
material
prices.
Volume
were
slightly
lower
in
Asia
because
of
the
value
chain
because
of
difficulties
in
getting
products
around,
transport
costs,
cost
of
containers
and
so
on
has
really jeopardized
the
way
you
could
move
goods
around
in
Asia.
EBITDA
was
down
DKK 90
million
to
DKK
315
million,
EBITDA
percent
from
19.2%
to
14%,
so
it
also
really
shows
significant
drive
down.
But
only
affected
by –
because
of
raw
materials,
we
had
a
negative
raw
material
effect
in
2021
of
DKK 77
million.
And
then
energy
also
exploded
for
FPC
very
big
energy
user.
Just
an
example,
also,
when
I
said
sending
materials
around
in
Asia,
we
are
supplying
from
Asia
to
US.
Container
used
to
be
$5,000
per
one
container
at
the
end
of
the
year,
it
was
$29,000.
So
this
is
really
something
that
is
difficult
to
work
on.
We
are
installing
the
new
line
9
in
Malaysia
getting
ready, 15,000
tonnes
capacity
starting
up
here
in
2022.
Line
2
print
facility
in
US
also
in
the
making
and
starting
to
produce
commercial
here
at
the
start
of
the
year.
Expect
to
continue
to
grow
top
line
expected
between
DKK 2.5
to
DKK
2.6
billion
and
EBITDA
in
the
range
of
DKK
310 million
to
DKK 350
million.
We
will
see
some
volume
effect
and
of
course
many
will
ask,
okay,
couldn't
we
see
a
higher
EBITDA
level when
you
expect
to
increase
your
top
line
and
your
volume?
But
we
also
have
to
take
costs
for
running
in
line
number
9
in
Malaysia.
And
we
have
also
decided
that
we
are
going
to
participate
in
some
of
the
cost
increases
in
the
transportation
around
Asia
to
help
our
customers
on
the
long
run.
So
in
2022,
we
expect
to
see
ourselves
also
sharing
some
of
– some
costs
that
are
exploding
towards
our
customers.
From
FPC
to
the
other
company
in
the
Fibertex
family,
Fibertex
Nonwovens,
experienced
extremely
volatile
and
demanding
year.
They
were
flying
in
half
one,
had
a
turnover
of
DKK
1.9
billion
for
the
year,
the
first
half,
all-time
high
profitability
fantastic.
And
second
half
dramatic
down,
very
low
profitability
more or
less
from
the DKK
127
million
EBIT
in
first
half
to
zero EBIT
in
second
half.
That's
really
dramatic.
That
was
due
to
our
huge –
a
lot
of
our
automotive
customers
stopped
their
activity
for
or
had
a
stop
and
go
strategy.
We
saw
our
US
wipes
business
were
hampered
because
of
inventory
build
and
a
lot
of
the
value-added
product
as
protective
face
masks
or
respiratory
face
masks
and
so
on
was
for
a
time
put
on
hold.
And
then
we
were
also
facing
here,
as
in
other
companies
exploding
costs,
especially
on
raw
materials
and
energy.
Profitability
was
[ph]
high
(00:15:44),
EBITDA
15%
down
to
DKK
230
million.
I
have
to
say
that
Fibertex
Nonwovens
have
worked
very,
very
hard,
pushing
so
hard on
getting
compensations
on
prices
and
so
on
and
succeeded
a
lot.
And
I
really
have
to
appreciate
what
the
organization
throughout
Fibertex
Nonwovens
have
been
for
handling
this
very
difficult
situation.
We
have
a
large
investment
program
ongoing,
decided
investments
of around
DKK
600
million
that
will
come
into
play
in
2023.
Two
new
lines,
one
in
US
and
one
in
the
Czech
Republic,
supplying
and
building
on
the,
what
we
call,
speciality
wipes
markets
in
this
segment
where
we
are
very
strong
and
we
also
expect
to
grow
a
lot
in
future.
2020
will
be
a
year
of
transition.
Expect
to
grow
the
top
line
between DKK
1.9
billion
to
DKK
2.1
billion.
EBITDA
will
be
down
compared
to
2021,
but
that
has
starting
point
that's
second
half
was
so
slow.
We
have
– we
begin
to
see
things
picking
up
again,
so
that's
positive.
But
of
course,
let's
see
what
happens
on
raw
materials
and
so
on.
But
demand
is
good,
margin
starts
to
improve,
and
the
organization
are
pushing
hard
for
cost
compensation
and
also
changing
the
mix.
So,
from
Fibertex
Nonwovens
or
from
the
two
Fibertex
companies, I'd
just
like
to
show
this
slide
here
where
you
could
see
three
of
the
most
important –
sorry,
I
have
to
go
back.
Yeah.
Where
you
could
see
the
three
most
important
raw
materials
in
Fibertex,
how
they
have
developed
throughout
2021.
Most
important
one
is
the
one
on
the
left
side
as
the
polypropylene
or
PP
where
we
use
more
than
100,000
tonnes.
Just
look
at
the
way
prices
have
increased
in
2021,
very
difficult
to
handle
and
work
with.
Average
now
€1,800
– €1,700
per
tonne.
And,
also,
viscose
and
virgin
PET
has
really
developed
a
lot.
So,
it
takes
a
lot
for
an
organization
to
handle
that.
You
continuously
need
to
work
with
adjusting
your
prices.
Normally,
we
adjust
prices
in
Fibertex
Personal
Care
every
quarter
and
Fibertex
Nonwovens
more
or
less
every
year.
Here,
you
have
maybe
been
out
adjusting
prices
10,
15
times.
Continues
to
work
on
that.
You
need
to
rethink
your
products.
You
need
to
redesign
how
can
you
do
to
get
around
these
prices.
So,
it
has
been
a
big
challenge,
but
good
that
we
have
a
lot
of
experience
in
the
companies
to
handle
this.
From
that,
moving
onto
GPV and
now
onto
the
three
companies
that
have
really
performed
very
well,
what
we
call
our
three
industrial
companies
has
– have
very,
very
strong
years
GPV,
build
on
a
strong
demand
across
all
their
segments,
growing
11%
to
DKK
3.2
billion
and,
in
fact,
getting
out
of
2021
with
an
all-time
high
backlog,
even
orders
covering
well
into
2023.
Strong
profitability.
EBITDA
up
27%
to
DKK
342
million.
We
had
a
positive
currency
effect
on
EBITDA
of
around
DKK
15
million,
but
still
strong
profitability.
Also
came
out
of
high
efficiency
and
capacity
utilization.
We
are
still
work –
GPV
is
still
improving
a
lot.
They
have
a
very
strong
pipeline
of
new
customers
going
well
into
the
coming
years.
One
thing
we
decided
to
do
in
GPV
when
this
difficult
component
situation,
freight
situation
started,
we
decided
we
need
to
build
inventory
on
what
we
call
critical
components.
So,
we
have
increased
inventories
in
GPV
with
around
DKK
600
million.
Strategic
decision
came
out
of
the
difficult
supply
situation,
and
I
think
as
we
speak,
we
are
very
positive
that
we
have
these
inventories
because
we
are
still
able
to
supply
customers
around
the
globe.
We
are
having
needed
capacity
increases
ongoing,
extending
our
two
signature
factories
in
Thailand
and
Sri
Lanka
expected
to
be
ready
in
2022,
beginning
2023.
So,
with
that,
I
can
say
GPV
expect
to
continue
strong
momentum
in
2022,
top
line
between
DKK 3.2
billion
to
DKK
3.4
billion,
EBITDA
DKK
300
million
to DKK
340
million.
Of
course,
supply
situation,
component
prices
and
so
on
is
difficult
to
forecast,
but
we
are
still
positive
on
the
development
there in
GPV.
From
there
to
HydraSpecma showed
very,
very
good
development,
global
OEMs
bounced
back.
All
the
global
OEM
customers
in
2020
were
really
suffering,
but
in
2021,
flying
high,
growth
17%
to
DKK
2.3
billion,
and
very
high
activity
level
across
all
segments
in
HydraSpecma.
Also
here,
we
have
all
time
high
backlog,
so
that's
very
positive.
Profitability
was
strong,
EBITDA
up
36%
to
DKK
286
million.
Here
we
also
have
to say
we
had
an
extraordinary
income
of
DKK
17
million,
but
again
still
good
and
solid
profitability
due
to
high
productivity
across
all
facilities
in
HydraSpecma.
And
they
have
also
had
a
lot
of
increasing
prices,
et cetera.
And
they
were
partly
offset
by
strong
pricing, excellent
strategy
throughout
the
company.
We
are
expanding
facilities
throughout
the
company.
We're
growing
with
our
customers.
We
are
building
new
in
Asia.
We
are
building
new
in
Poland.
And
we
are
exercising
what
we
call
the
best
cost
country
strategy
looking
at
where
do
we
have
the
best
cost
opportunities
and
utilizing
that.
HydraSpecma
we
will
build
on
a
solid
backlog.
Expect
top
line
to
be
between
DKK
2.3
billion
and
DKK 2.5
billion.
EBITDA,
around
DKK
260
million to
DKK
290
million
as
we
speak.
Moving
on
to
the
last,
but
not
least,
company
in
our
portfolio,
Borg
had
a
very
busy
year
with
both
acquisitions
and
integrations.
Top
line
we're
growing
57%
to
DKK
1.36
billion.
Borg
came
out
from
a
very
difficult
2020
where
they
had
months
where
the
sales
were
very
low,
but
Borg
regained
18%
organic
growth
on
the
reman
products,
reman
strategy
strengthening.
DKK
345
million
of
the
growth
came
from
the
acquired
companies
TMI
in
Spain
and
the
new
SBS.
Profitability
were
improved
in
general.
EBITDA
plus
50% to
DKK
162
million,
of
course,
also
some
effects
from
acquisitions.
But
as
I
said,
the
reman
business
doing
very
well.
Efficiency
improved
throughout
the
entire
company.
We
took
over
SPS
as
a
new
activity
from
July
2022.
SPS
is
a
trading
company
with
their
own
brands,
two
brands,
NK
and
Eurobreaks
having
160
employees,
strong
positions
in
Germany
even
in
Russia
and
in
France,
a
company
we
extend
– we
have
intention
to
build
on
and
to
develop
brands
with.
Borg,
expect to
continue
to
grow,
top
line
DKK 1.6
billion
to
DKK
1.8
billion
and
EBITDA
around
DKK
170 million
to
DKK
200
million.
So,
we
really
have
now
moved
Borg
in
the
right
direction
and
can
see
DKK
2
billion
company
not
too
far
away.
So,
with
that
very
short
dive
into
each
of
our
portfolio
companies,
let
me
just
elaborate
a
little
bit
on
our
2022
guidance.
And
I
think
as
a
starting
point,
we
should
say
we
expected
really
2022
to
be
a
very
good
year,
high
activity.
We
have
a
solid
backlog,
a
lot
of
things
with
our
customers
we're
going
on.
We
have
added
new
capacity.
We
see
opportunities
but
we
did
not
take
into
consideration
the
critical
development
in
Ukraine
and
it
is
not
factored
into
the
actual
guidance.
But
just
to
lift
a
little
bit
on
uncertainty,
I
could
say
of
course
uncertainty
increased
but
our
activities
in
Russia
Ukraine,
they
are
not
that
big.
It's
around
1.4%
of
our
top
line.
We
do
not
have
any
production
facilities
in
either
Russia
nor
Ukraine.
But
of
course,
we
have
sales,
sales
of
around
DKK
350
million,
mainly
coming
from
BioMar,
Denmark,
and
from
the
newly
acquired
SBS.
And
we
have
also
feet
on
the
ground
in
Russia,
a
small
organization
over
there.
But
this
guidance
here
does
not
include
any
kind
of
uncertainty
from
that
situation
there.
So
we
still
guide
a
growth.
Top
line
2
– DKK
25.5
billion
to
DKK
27.5
billion.
EBITDA
having
a
more
broader
or
wider
range,
DKK
2.15
billion
to
DKK
2.4
billion.
And
as
I
said,
when we
looked
into
the
year,
months
ago,
we
were
very
optimistic
on
this
guidance.
We
are
still
positive
on
the
guidance,
but
of
course,
we
also
have
to
be
realistic
on
what's
going
on
around
the
world.
We
have
a
general
global
concern
on
input
costs,
energy,
freight,
and
so
on,
and
we
are
looking
into
that,
but
we
have
not
seen
anything
that
change
our
present
outlook.
So,
with
that,
just
the
last
slides
also
saying
that,
of
course,
we
have
a
lot
of
priorities
at
group
and
company
level.
We
work
with
a
clear
road
map
on
how
to
continue
to
be
profitable
and
create
growth
within
the
group.
We
have
four
priorities
we
expect
to
deliver
on
and
we
have
put
a
lot
of
activities
around.
We
want
to
improve
profitability
in
general.
We
have
pricing
excellence
teams
working
into
secure
that
we
can
pass
on
all
increasing
costs.
We
have
expanded capacity
also needs
–
means
that
we
need
to
go
in
the
market
and
get
sufficient
volume
in
the
long
run.
We
have
to
balance
our
net
working
capital,
but
also
to
understand
the
market
dynamics.
And
then,
we
–
as
a
new
thing,
not
a
new
thing,
we
will
work
on
it
a
lot
but
we
have
put
ESG
on
as
a
strategic
lever
for
Schouw.
And
we
are
pushing
hard
on
creating
value
and
at
the
same
time
being
a
very
responsible
company.
So
with
that
note,
I
think
I
will
just
put
on
the
next
one
and
then
open
up
for
Q&As.
Thank
you.
Claus
Almer.
Yes.
I
will
start
out
with
a
few
question
and
I
will
wait
for
the
most
obvious
question
Jens for
later.
Yes.
I
know
what
it
is,
so
thanks.
So,
the
first
will
be
for
your
2025
targets.
Yeah.
First
of
all,
why
did
you
not
decide
to
single
out
the
M&A
impact?
It
is
slightly
difficult
to
use
your
2025
targets
if
that
includes
M&A
impact,
which
we
don't
know
what
is.
That
will
be
the
first
question.
Yes.
No.
Claus,
thank
you
for
that
and
I
agree
with
you.
When
we
say
including
M&As,
you
also
know
we
have
small
M&As
going
on
every
year.
As
you
saw
this
year,
we
had
the
TMI,
SBS
with Borg
and
so
on.
Most
of
the
expected
growth
will
be
organic.
That's
what
we
expect.
We
have
also
set
in
capacity
investments
and
so
on
to
meet
that
target.
So,
we
do
not,
in
this
target,
foresee
any
major
acquisitions.
So,
it's
more,
can
I
say,
like
that
business
as
usual,
M&A,
small
bolt-ons,
easy
to
integrate
into
each
of
our
companies.
So,
that's
with
that
in
mind,
Claus.
Okay.
And
then
–
so,
now
you've
set
a
new
direction
or
set
of
direction
for
2025.
It's
a
little bit
difficult
from
the
outside
to
figure
out,
but
have
you
also
– does
this
mean
a
change
of
your
strategy
for
the
individual
divisions
or it's
more
as
we
know
Schouw?
No,
it's
also
– of course,
it's
built
on
the
back
of
what
we
see
from
each
of
our
companies.
So,
we
run
a
strategy
exercise
every
year
and
update
forecast
and
so
on,
and
we
just
had
our
strategies
seminar
here
in
January
and
then
actually
looking
into
our
2025
strategy,
we
call
it
Build
Future
and
we
could
see
this
is
where
we
expect
to
come.
And
we
thought
it
was
time
also
to
disclose
to
the
market
that
we
are
a company
that
intend
to
grow,
we
are
ambitious,
built
on
the
companies
we
are
having
in
our
portfolio
now
and
not
including
very
big
acquisitions.
But,
of
course,
each
company,
they
have
– had
a
strong
strategy
process
and
have
plans
for
how
to
deliver.
But
what
–
okay.
But
now,
you're
making
all
these
cash
flow and
we've
been
discussing
this
in
the
past.
So,
why
don't
you
be
more
precise
or
more
ambitious
on
your
M&A
journey?
No.
But
I
think
it's
–
you're
right
asking
that
question,
but
you
also
know,
Claus,
it
is
difficult
to
be
specific
to
say,
okay,
now
we
are
going
to
make
acquisitions
of
this
and
this
size
and
so
on
because
do
we
find
the
right
companies,
do
we
do
– could
we
find
them
at
an
attractive
pricing
and
so
on.
But
let
me
be
very
clear
and
say
we
also
have
intention
of
being
acquisitive
also
if
something
very
attractive
and
big
comes
up.
As
I
think
I
started
saying,
we
have
a
lot
of
buying
power
and
we
intend
to
use
that
to
create
value
also
in
future,
so
yeah.
Okay.
And
then,
jumping
to
BioMar,
you
mentioned
Jens that
cost
inflation
or
input
cost
inflation,
freight
costs
and
so
on
was
difficult
to
pass
through
to
the
clients.
Yeah.
Normally,
you
have
a
sort
of
a
pass-through
structure.
And volume
is
good.
Is
this –
of
course,
the
situation
in
Chile
is
maybe
a
little
bit
not
the
ordinary
as
we
know
about
BioMar.
But
can
you
try
to
add
some
color
to
the
pricing
discipline
in
the
market
and
for
you?
And
what
should
we
think
about
cost
inflation
being
passed
through
to
clients?
Yeah.
There
are
several
things
and
you
are
elaborating
right
on
that.
And
that
– but
one
thing
is
main
cost
contracts
or
cost
plus
and
pass-on
mechanism
is
within
the
salmon
segment.
The
other
segments
are
much
more
fragmented.
We
don't
have
the
same
ability
just
to
go
out
and
say,
okay,
cost
increased
that
much,
so
you
have
to
do
it,
so.
So,
it's
–
it
goes
for
salmon.
But
I
think
also
we
build
on
industry
kind
of
contract
structure,
saying
that
it's
only
raw
materials
you
can
do
it
on.
But
we
have
had
a
lot
of
other
costs
exploding
as
energy,
transportation
and
so
on.
And
that's
not
built
into
the
contracts
in
the
same
way
also,
meaning
that
we
are
rethinking
how
should
we
try
to
build
contract
structures in
the
future?
On
the other
hand also,
we have
had
some
raw materials
that
all, by
a sudden,
became scarce,
and
we couldn't
get
them.
And
then,
we
had
to reformulate
and
do
a lot
of things.
So,
it
has
really
been
very
difficult.
But
the
direct
raw
materials'
cost
to
large
salmon,
cost
how
much?
You
can
pass
on
within
a
month
or
things
like
that,
how
it's
said
in
the
contract,
but
energy,
transport,
and
so
on, it
doesn't
go
in
the
same
way.
So,
we
have
to
look
into
how
do we
see
contract
structures
in
future
and
something
we
are
rethinking
for
the
time.
Okay. And
then,
just
a –
the
final
question,
and
that
goes
to
net
working
capital
Jens...
Yeah,
yes.
...a
old
good
topic
and,
of
course,
I
acknowledge
that
your
revenue
growth
means
higher
net
working
capital
and
also
the
situation
within
[ph]
P2P (00:34:26).
But,
still,
I
think
it
was
a
high
level
you
ended
the
year.
So,
maybe
to
ask
it
in
another
way,
how
should
we
think
about
the
level
when
you
are
leaving
2022?
Yeah
– No.
But
I
think,
we
should
be
very
honest
and
open.
We
have –
we
said,
okay,
it's
a
strategic
decision.
But,
I
have
to
say
myself
also,
I
got
surprised
that
it
had
to
increase
that
much,
and
it
happened
very
fast
also
because
of
price
increases
and things
like
that.
So,
I
cannot
stand
here and
say
that.
That
was
100%
as
we
expected
it,
but
we
took
a
strategic
decision,
saying
that we
need
to
build
inventories
and
so
on
but
our
net
working
capital
is
at
the
high
end
and,
I'd
tell
you, it's
something
that we
have
been
discussing
a
lot
around
the
table
here.
But
you
should
expect
it
to
decrease
in
2022.
We
are
putting
a
lot of efforts
into it
also because,
when
you
have
strategic
build
inventories,
you
need
to
be
sure
also
to
– you
have
the
inventories
at
the
right
prices.
What
happens
if
market
suddenly
starts
to
deteriorate
and
do
we
then
sit
with
too
high
component
prices
and
so
on?
So,
it's
something
that
is
very
high
at
the
agenda,
but
we
have
been
calm
in
2021
because
it
was
necessary.
But
believe
me,
we
are
focusing
it
a
lot,
and
I
have
been
a
little
bit
surprised.
I
would
lie
if
I
didn't
said
that,
So,
it
would
come
down
in
absolute
or
as
percentage
of
revenue.
That
we
will
–
we
work
on
a
percentage
of
revenue,
but
we
also
look
into
inventory
days,
[ph]
debtor
(00:36:12)
days,
things
like
that.
So,
there
is
a
lot
of
components
that
we
play
on.
And
I
think
also
we
have
– we
took
also
a
decision
to
say
that
some
of
our
customers,
we
need
to
protect
and
help
some
of
our
customers,
meaning
we
are
extending
their
credit
days
if
we
think
there
is
security
behind
it.
And
I
think
let's
say
that
the
situation
gets
difficult
in
2022,
then
we
intend
to
use
that
facility
again
because
we
can.
Sure.
But
do
you
think
in
a
normal
situation
as
it
is
today,
would
– will
your
net
working
capital
in
absolute
terms
be
lower,
at
the
same
level
or
higher
when
we
are
leaving
this
year?
In
absolute
terms,
I
could
put
it
that
way,
depending,
of
course,
on
the
activity
level
if
that
increases
a
lot.
But
in
percentage,
we
will
see
it
down,
and
we
will
also
see
inventory
days et
cetera
coming
down.
Absolutely.
Okay.
I
will
–
I
have
to
just
use
that
reply.
Thank
you
so
much,
Jens.
Thank
you,
Claus.
Thank
you
for
your
questions.
Was
it
[ph]
Claus
Keil (00:37:26) that
was
on?
Yeah.
[ph]
Claus (00:37:29).
Yes,
hello.
Hello,
[ph]
Claus (00:37:35).
A
question
related
to
your
guidance.
Obviously,
you
stick
to
your
guidance
for
2022.
But
you
also
say
that
yeah,
risk
has
increased
following
what
is
going
on
in
Ukraine,
and
I
can
fully
understand
that.
And
I
guess
it's
not
your
direct
exposure
to
Russia
that
I
should
be
most
concerned
about.
What
I'm
more
concerned
about
is
your
input
cost,
your
energy
cost,
everything
that
goes
into
your
production.
So
generally
speaking,
are
you
hedged
for
2022?
Or are
you
buying
in
the
spot
market?
And
what
kind
of
input –
sorry.
What
kind
of
impact
could
it
have
if,
for
instance,
gas
prices
stays
at
current
levels
for
the
next,
let's
say,
six
months?
Yeah.
We
have
factored
high
gas
prices,
et cetera,
into
our
guidance.
And
we
are
hedged
at
certain
level.
So
we
have some
hedging.
Hello?
Somebody
is
– should
unmute. Okay.
[ph]
Claus (00:38:43),
can
you
hear
me?
Yes.
I
can
hear
you.
Sorry.
There
was
a
lot
of
noise.
Somebody
unmuted
and
had
a
lunch
going
on
or
something.
But,
no,
[ph]
Claus (00:38:55),
we
have
hedged
some
of
our
energy,
of
course,
also
for
a
longer
time
and
so
on.
And
we
have
factored
rather
high
energy
costs
into
our
guidance.
But,
of
course,
if
things
really
goes
bananas,
we
have
to
readjust,
and
we
are
following
the
situation,
I
would
say,
on
a
weekly
basis.
And
if
things
really
happens,
we
had
to
come
out
to
the
market
again
and
clarify
how
we
see
things
and
so
on.
But
for
the
time
being,
we
still
think
that
we
are
covered.
And
that's also
including
what
has
been
going
on
for
the
last
week.
Yeah,
you
could
say.
Of
course,
we
see
some
[indiscernible]
(00:39:37),
and
we
have
not
taken
what's
going
on
the
last
week
into
our
guidance.
I
said
that
also.
We
have
– it
has
been
impossible
to
evaluate
still,
but
we
are
looking
at
it,
as
I
say,
on
a
weekly
basis.
We
have
a
follow-up
meeting
in
our
executive
committee
at
4:00
today
where
we
are
looking
into
where are
we,
what
happens,
and
so
on,
and
we
need
to
do
that
every
week
now.
Okay.
Great.
Thank
you very
much.
Thank
you,
[ph]
Claus (00:40:05).
Super.
As
we
can
see
on
the
screen,
no
more
questions.
So,
thanks
to
everyone
for
listening,
also
thankful
for
the
questions.
And
I
wish
all
of
you
a
very
good
weekend
in
spite
of
these
dark
times.
Yeah.
Thank
you very
much.